EUVIMEDEUVIMED entdecken
Crossref

Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review

Miriam Čupić, Jelena Dumančić, Ines Potočnjak, Iva Klobučar, Matias Trbušić, Vesna Degoricija

Endocrine Oncology and Metabolism · 2016

DOI: 10.21040/eom/2016.2.3.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Oncology and Metabolism, 2016. Verfasst von Miriam Čupić und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Čupić, M., Dumančić, J., Potočnjak, I., Klobučar, I., Trbušić, M., & Degoricija, V. (2016). Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review. Endocrine Oncology and Metabolism. https://doi.org/10.21040/eom/2016.2.3.6

Vancouver

Čupić M, Dumančić J, Potočnjak I, Klobučar I, Trbušić M, Degoricija V. Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review. Endocrine Oncology and Metabolism. 2016. doi:10.21040/eom/2016.2.3.6

BibTeX
@article{upi2016,
  author = {Čupić, Miriam and Dumančić, Jelena and Potočnjak, Ines and Klobučar, Iva and Trbušić, Matias and Degoricija, Vesna},
  title = {Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review},
  journal = {Endocrine Oncology and Metabolism},
  year = {2016},
  doi = {10.21040/eom/2016.2.3.6}
}
Kostenlos starten →